Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1580

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 1580
---
 Related Procedures.

The
Company adopted an insider trading policy governing the purchase, sale, and other dispositions of the Company’s securities by directors,
senior management, and employees. A copy of the insider trading policy is filed as an exhibit to this Annual Report on Form 10-K.

Communications
with the Board

Stockholders
and other interested parties can send communications to one or more members of the Board by writing to the Board or specific directors
or group of directors at the following address: Jupiter Neurosciences, Inc. Board of Directors, c/o Corporate Secretary, 1001 North US
Hwy 1, Suite 504, Jupiter, FL 33477. Any communication will be promptly distributed by our Corporate Secretary to the individual director
or directors named in the communication or to all directors if addressed to the entire Board.

102

Limitation
on Liability and Indemnification of Officers and Directors

Our
certificate of incorporation provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware
law, as it now exists or may in the future be amended. In addition, our certificate of incorporation provides that our directors will
not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent such exemption
from liability or limitation thereof is not permitted by the Delaware General Corporation Law (“DGCL”).

Our
certificate of incorporation also permits us to maintain insurance on behalf of any officer, director or employee for any liability arising
out of his or her actions, regardless of whether Delaware law would permit such indemnification. We have purchased a policy of directors’
and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of
a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.

These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions.

We
believe that these provisions and the insurance are necessary to attract and retain talented and experienced officers and directors.

ITEM
11. EXECUTIVE COMPENSATION